Tag Archives: HBAN

where to invest money

Elevator Pitch

Though traditionally a company’s Initial Public Offering prospectus is vague and difficult to sort, Mota Group’s (Pending:MOTA) prospectus clearly shows a troubled organization, with troubled leadership and a flawed business plan. The company’s drones will likely fly higher than the post-IPO stock price, and I would avoid or short.

Company Description (from the company’s prospectus)

MOTA Group (“the company”) designs, manufactures and markets consumer products – including recreational and commercial drones, smart wearables and innovative mobile accessories for smartphone and camera users. The company tries to identify opportunities where users can benefit from new technology, identifies the gaps and areas that can be simplified and enhanced, and develops these opportunities into products. Since 2012, MOTA has sold and shipped over 1.7 million units worldwide.

Mota Group has two principal divisions:

MOTA – Develops, manufactures and markets recreational and commercial drones and other unmanned aerial systems, also known as unmanned aircraft systems or UASs. The company has two lines of drones: recreational (consumer) drones (under our JETJAT brand) and UAS platforms for commercial applications (under our Pro Live and GIGA brands). Many MOTA drones are capable of delivering real-time video, automatic control, tracking and geographic data, which increases flexibility in planning and execution. TAMO – Designs, manufactures and markets stylish wearables, including smartwear, virtual reality products, portable power products and mobile accessories.

Thesis and Catalyst For Mota Group (MOTA pending)

where to invest money: Brooks Automation Inc.(BRKS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology sector was the top gainer in the US market on Monday. Top gainers in the sector included Aviat Networks Inc (NASDAQ: AVNW), Cohu, Inc. (NASDAQ: COHU), and Brooks Automation, Inc (NASDAQ: BRKS).

  • [By Lisa Levin]

    In trading on Friday, technology shares fell 3.59 percent. Meanwhile, top losers in the sector included Ultra Clean Holdings Inc (NASDAQ: UCTT), down 5 percent, and Brooks Automation, Inc (NASDAQ: BRKS), down 10 percent.

where to invest money: California Resources Corporation(CRC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    That sell-off in the oil market weighed on financially challenged oil stocks, which will struggle if crude continues dropping. Among the biggest losers were Abraxas Petroleum (NASDAQ:AXAS), Whiting Petroleum (NYSE:WLL), Denbury Resources (NYSE:DNR), California Resources (NYSE:CRC), and Cobalt International Energy (NYSE:CIE).

  • [By Andrew Efimoff]

    WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:

    California Resources Corporation (NYSE: CRC): -19.22%
    Dynamic Materials (NASDAQ: BOOM): -12.39%
    Clayton Williams Energy (NYSE: CWEI): -11.45%
    Dynergy (NYSE: DYN): -11.91%
    EP Energy Corporation (NYSE: EPE): -11.20%
    Mexco Energy (NYSE: MXC) -10.90%
    Whiting Petroleum (NYSE: WLL) -10.79%
    Southwestern Energy Company (NYSE: SWN) -10.79%
    SM Energy Company (NYSE: SM) -10.38%
    Real Goods Solar (NASDAQ: RGSE) -10.34%

    Posted-In: Commodities After-Hours Center Markets Movers

  • [By Lisa Levin]

    On Friday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Denbury Resources Inc. (NYSE: DNR) and California Resources Corp (NYSE: CRC).

where to invest money: Huntington Bancshares Incorporated(HBAN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Who is at the lower-end of the range for 2016 payout ratios? We expect Zions Bancorporation, Huntington Bancshares (HBAN), andBank of America to seek the least amount of capital return in 2016 (ranging between 50-60% of estimated earnings).

where to invest money: Concord Medical Services Holdings Limited(CCM)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday,our Under the Radar Moversnewsletter suggested going long on small cap China basedhealthcare equipment and management services stock Concord Medical Services Holdings Ltd (NYSE: CCM):

Top 5 Blue Chip Stocks To Buy Right Now

When I initiated coverage on Xerox (NYSE:XRX), I concluded that the stock wasn’t dead, and in January, I opined the name was also not “dead money.” That is important to reiterate. But this once stellar blue chip has certainly fallen from grace, big time. I then told you that the company was “not dead yet.” But friends, are we approaching the death of Xerox? I mean, it has been struggling for a long time. I suggested on nice dips you could buy simply for the yield and collect the dividend, but growth was nowhere to be found. I said had in my prior work numerous times that we needed to see some improvement in the underlying metrics before I could get behind the name. Well, in the past three months, the stock has moved sideways to higher, but will there be sustained momentum? That is tough to tell, but the name has been downgraded and the most recent earnings were not great.

The truth is that performance has been pitiful of late and is the reason shares have declined. Well here, Q3 shows that there are still declining revenues. Revenue as a whole came in at $4.21 billion, and this messed estimates by $100 million. However, this was also down 5.4% year over year, continuing a string of declining quarters. In addition the degree of declining revenues seems to be picking up and this is real bad news. Of course, as I have discussed in-depth in other articles, the strong dollar has hurt companies with international businesses.

Top 5 Blue Chip Stocks To Buy Right Now: magicJack VocalTec Ltd(CALL)

Advisors’ Opinion:

  • [By Monica Gerson]

    magicJack VocalTec Ltd (NASDAQ: CALL) is projected to post its quarterly earnings at $0.30 per share on revenue of $25.00 million.

    Rentech, Inc. (NASDAQ: RTK) is estimated to post a quarterly loss at $0.08 per share on revenue of $81.02 million.

  • [By Peter Graham]

    Any smidgen of magic left in magicJack VocalTec (CALL) is vanishing quicker than street magician David Blaine can make a new quarter disappear.

    Now the former star of annoying, late-night TV commercials only wishes it could make its melting core business model reappear.

  • [By Peter Graham]

    Any smidgen of magic left in magicJack VocalTec (CALL) is vanishing quicker than street magician David Blaine can make a new quarter disappear.

    Now the former star of annoying, late-night TV commercials only wishes it could make its melting core business model reappear.

Top 5 Blue Chip Stocks To Buy Right Now: Huntington Bancshares Incorporated(HBAN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Who is at the lower-end of the range for 2016 payout ratios? We expect Zions Bancorporation, Huntington Bancshares (HBAN), andBank of America to seek the least amount of capital return in 2016 (ranging between 50-60% of estimated earnings).

Top 5 Blue Chip Stocks To Buy Right Now: Yandex N.V.(YNDX)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Somerset Capital Management LLP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Somerset+Capital+Management+LLP

    These are the top 5 holdings of Somerset Capital Management LLPFomento Economico Mexicano SAB de CV (FMX) – 1,268,818 shares, 36.15% of the total portfolio. Shares reduced by 9.36%Yandex NV (YNDX) – 3,352,412 shares, 25.48% of the total portfolio. Shares reduced by 3.61%ICICI Bank Ltd (IBN) – 5,074,899 shares, 13.19% of the total portfolio. Shares reduced by 11.08%Infosys Ltd (INFY) – 1,596,414 shares, 6.95% of the total portfolio. Shares reduced by 15.58%KT Corp (KT) – 1,330,431 shares, 6.41% of the

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Lee Jackson]

    Yandex N.V. (NASDAQ: YNDX) is the Google of Russia. It was very bold on the growing marketplace there, and its beta tests of a new back end have been very positive and should be rolled out soon. Deutsche Bank has a $38 price target, and the consensus is $40, in U.S. dollars.

  • [By Steve Symington]

    Yandex N.V.(NASDAQ:YNDX)announced exceptional first-quarter 2017 results on Thursday, highlighted by a recent antitrust deal with Google, stabilizing market share in its core search segment, and strong growth from its various other business units.

  • [By Peter Graham]

    A long term performance chart shows Alphabet Inc being in a relatively steadyuptrend compared withsearch engine peerslike Yahoo! Inc (NASDAQ: YHOO), China basedBaidu Inc (NASDAQ: BIDU) and Russiafocused mid cap Yandex NV (NASDAQ: YNDX):

Top 5 Blue Chip Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

  • [By Lisa Levin]

    Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

Top 5 Blue Chip Stocks To Buy Right Now: Molson Coors Brewing Company(TAP)

Advisors’ Opinion:

  • [By ]

    Not to be outdone, industry behemoth Molson Coors Brewing Co. (NYSE:TAP) announced it might soon throw its hat into the ring. Think about it one of the most recognizable big brewers in the country will soon look to expand into the cannabis business.

  • [By Mark Fritz]

    Price Target: 116 euros.

    Molson Coors Brewing Co (NYSE: TAP): Sell.
    Price Target: $78.

    Boston Beer Company Inc (NYSE: SAM): Sell.

    Price Target: $124.

  • [By Jayson Derrick]

    The Canadian beer market, much like the American beer market, is seeing a growth in craft products at the expense of established players. And one of the biggest established beer makers in Canada is Molson Coors Brewing Co (NYSE: TAP), Bereneberg’s Javier Gonzalez Lastra and Matt Reid commented in an initiation note.

  • [By WWW.THESTREET.COM]

    In the past, Cramer has been a fan of both Constellation as well as Molson Coors (TAP) , which was able to snap up all the Miller and Coors brands last year for $12 billion. That deal is expected to boost Molson’s earnings by 25% this year.

  • [By Seth McNew]

    It isn’t the only beer company facing hardships now, and in fact, it’s still growing faster than its largest competitors — Sam Adams parent Boston Beer (NYSE:SAM) and Molson Coors Brewing (NYSE:TAP). Boston Beer’s total sales fell 5.4% in 2016, year over year, and Molson Coors’ sales were down 2.3%.

Top 10 Stocks To Watch For 2018

Jim Cramer shares his views every day on RealMoney. Click here for a real-time look at his insights and musings.

Cramer: Fundamentals Provide a Dose of Reality

Posted at 2:39 p.m. EDT on Wednesday, Dec. 21, 2016

We always have to keep one eye on the fundamentals during this period of what many describe as total excess. We have to use the data we can grab to be able to make a case that we aren’t going too far too fast beyond the promises that we’ve gotten from President-elect Trump, promises that have to come true or else we are in for a serious correction in the first quarter of 2017.

Fortunately, we have both macro or top-down data and micro or individual company reports, to do a reality check.

For example, we got existing-home sales, which were quite strong–5.61 million in November, the best since February 2007. I can’t stress how important that figure is. Robust existing-home sales are crucial to all sorts of businesses, from banks to retailers to service companies that help install and renovate.

Top 10 Stocks To Watch For 2018: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top 10 Stocks To Watch For 2018: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    Shares of Hangzhou, China-based NetEase Inc (NASDAQ:NTES)popped 14% in the Feb 16th trading session after the company reported stellar Q4 and full-year 2016 earnings on Feb 15th after market close. The Chinese online gaming giant delivered an EPS of $4.30 on revenues of $1.74B beating EPS estimates by $0.86 and revenue estimates by $16oM. NetEase’s revenue grew by an impressive 53.1% YoY for Q4 and 67.7% for the full year 2016. On the back of these strong numbers, NTES stock closed at an all-time high of $298.73 in yesterday’s trading session. NTES stock might have gone up very high too soon. There could be a correction around the corner but still NTES stock is a great long-term proposition with much more upside left. Here’s why.

  • [By Joe Tenebruso]

    Shares ofNetEase (NASDAQ:NTES)popped 20.1% last month, according to data provided byS&P Global Market Intelligence, as the Chinese internet technology company’s strong fourth-quarter earnings report was applauded by investors.

Top 10 Stocks To Watch For 2018: Texas Roadhouse, Inc.(TXRH)

Advisors’ Opinion:

  • [By Joe Tenebruso]

    Fortunately, well-chosen dividend-growth stocks can help you accomplish both of these goals. And with its powerful wealth-building combination of increasing dividend payouts and share-price appreciation, Texas Roadhouse (NASDAQ:TXRH)is one of the best available in the market today.

  • [By Jon C. Ogg]

    Texas Roadhouse Inc. (NASDAQ: TXRH) was raised to Buy from Neutral at BTIG Research.

    USG Corp. (NYSE: USG) was reiterated as Hold but the price target was raised to $35 from $29 (versus a $34.23 close) at Jefferies.

  • [By Dan Caplinger]

    Steakhouse chain Texas Roadhouse (NASDAQ:TXRH) has had to deal with an extremely difficult business environment for restaurant companies, and investors know all too well how tough times can hurt major players in the industry. Last quarter, Texas Roadhouse disappointed investors with sluggish results, and the company wanted to start 2017 on a better footing.

  • [By Teresa Rivas]

    Texas Roadhouse(TXRH) tumbled more than 12% on Wednesday as itsfourth-quarter earningsand revenue fell short of expectations.

    Pixabay

    The restaurant chain said it earned 29 cents a share on revenue of $484.7 million. Analysts were expecting earnings per share of 38 cents on revenue of $497.3 million.

    Same-restaurant sales grew 1.2% at company restaurants and 2% at domestic franchises. For the first 55 days of the first quarter, Texas Roadhouse said that same-store sales rose 1.5%.

    The company also raised its dividend 10.5% to 21 cents a share.

    Some analysts urged investors to keep the faith in the stock.Barclay’s JeffreyBernsteinreiterated an Overweight rating and $47 price target on thestock:

    We believe TXRH fundamentals remain best-in-class. That said, the near-term focus remains on directional comps. And not unlike the broader industry, TXRH comps eased significantly to close 2016. Such led to disappointing 4Q16 results from top to bottom. Importantly, while the brand ‘is not immune’ to industry comp headwinds, the relative outperformance to the category was maintained. Looking to 2017, key guidance metrics were reiterated. While questions remain on whether the recent easing of industry comps will persist, we remain comforted by TXRH’s relative outperformance and easing comps as we move through 2017.

    Maxim’s Stephen Andersonreiterated a Buy rating, although he took his price target down $4, to $52:

    In our view, TXRH is not immune to the broader slowdown in Casual Dining, but we believe the company will emerge stronger than peers in the next few quarters.TXRHs disappointing 4Q16 comp of +1.3% (blended) was pulled down by a rare negative comp month in December (-2.1%), marking the first time this occurred in almost four years. Comps were +3% or better in both October and November, and comps so far in 1Q17 are positive despite a stormy start to the quarter in

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Texas Roadhouse (NASDAQ:TXRH) and Garmin (NASDAQ:GRMN)made large moves following their quarterly earnings announcements.

Top 10 Stocks To Watch For 2018: Mosaic Company (The)(MOS)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was The Mosaic Co. (NYSE: MOS) which traded down 2.4% at $23.09. The stocks 52-week range is $22.43 to $34.36. Volume was 4.2 million versus the daily average of 5.1 million shares.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Ben Levisohn]

    Mosaic (MOS) tumbled to the bottom of the S&P 500 today after announcing that it would buy Vale’s (VALE) fertilizer unit.

    Getty Images

    Mosaicdropped 1.1% to $27.77 today, while the S&P 500 advanced 0.2% to 2,262.53.

    Barron’s Dimitra DeFotis covered the deal over at Emerging Markets Daily:

    Global agricultural chemicals giant Mosaic (MOS) is buying most of the fertilizer chemicals business of Brazilian mining giant Vale (VALE) in a cash-and-stock deal valued at $2.5 billion, but Wall Street doesnt seem to like the deal…

    Vale will maintain an 11% stake with ownership nitrogen and phosphate fertilizing assets in the city of Cubat茫o, Reuters reports. Mosaic adds Canada and Peru mines to its empire as part of the deal, according to the Mosaic acquisition press release…

    Mosaic’s market capitalization fell to $9.7 billion today from $10.4 billion yesterday. It reported net income of $1 billion on sales of $8.9 billion in 2015.

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

Top 10 Stocks To Watch For 2018: Huntington Bancshares Incorporated(HBAN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Who is at the lower-end of the range for 2016 payout ratios? We expect Zions Bancorporation, Huntington Bancshares (HBAN), andBank of America to seek the least amount of capital return in 2016 (ranging between 50-60% of estimated earnings).

Top 10 Stocks To Watch For 2018: Hexcel Corporation(HXL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Hexcel Corporation (NYSE: HXL) issued a weak profit and sales forecast for 2017.
    VeriFone Systems Inc (NYSE: PAY) reported better-than-expected earnings for its fourth quarter, but issued a weak outlook for the first quarter.
    Boeing Co. (NYSE: BA) lifted its quarterly dividend by 30 percent to $1.42 per share. The company’s board also announced a a new $14 billion share buyback plans.
    Inovalon Holdings Inc (NASDAQ: INOV) cut its earnings and revenue guidance for full year 2016.

Top 10 Stocks To Watch For 2018: Aurinia Pharmaceuticals Inc(AUPH)

Advisors’ Opinion:

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
    Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
    Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
    aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
    Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
    Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
    Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
    Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
    Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Lisa Levin]

    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares shot up 24 percent to $4.60 after the company disclosed that Voclosporin met 48-week remission endpoints.

  • [By Todd Campbell]

    After positive mid-stage trial data suggested earlier this year that it might be able to reshape the treatment of kidney failure in lupus patients, Aurinia Pharmaceuticals (NASDAQ:AUPH)has announced plans for a late-stage study that could eventually allow it to win regulatory OKs in the U.S., Europe, and Japan.

Top 10 Stocks To Watch For 2018: Noah Holdings Ltd.(NOAH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Noah Holdings Limited (ADR) (NYSE: NOAH) is estimated to post financial results for its latest quarter.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top 10 Stocks To Watch For 2018: MercadoLibre Inc.(MELI)

Advisors’ Opinion:

  • [By Javier Hasse]

    “Take Mercadolibre Inc (NASDAQ: MELI), for example. When the stock market fell, they had enough cash in the bank to weather the storm; meanwhile, competitor DeRemate didn’t, and thus ended falling in oblivion. So, the lesson is: money is not a commodity.”

  • [By Rick Munarriz]

    Shares of MercadoLibre (NASDAQ:MELI) hit an another all-time high last week, and there’s another Wall Street pro who thinks the dot-com darling is going even higher.Barclays analyst Deepak Mathivanan initiated coverage of MercadoLibre with an overweight rating after Tuesday’s market close. He’s setting a $250 price target on the stock, translating into 18% of upside from yesterday’s close.

  • [By Brian Feroldi, Dan Caplinger, Rich Duprey, Jason Hall, and Jordan Wathen]

    So what other companies could potentially grow at a breakneck speed over the next few decades? We asked a team of Fools that very question, and they pickedMercadoLibre (NASDAQ:MELI),WisdomTree Investments(NASDAQ:WETF),Illumina (NASDAQ:ILMN), First Solar (NASDAQ:FSLR), andNVIDIA (NASDAQ:NVDA). Read on to find out why.

Top 10 Stocks To Watch For 2018: NextEra Energy Partners, LP(NEP)

Advisors’ Opinion:

  • [By Travis Hoium]

    Don’t look now, but the demise of the solar yieldco industry may have been overstated. In the past six months, NextEra Energy Partners (NYSE:NEP), NRG Yield (NYSE:NYLD), and Pattern Energy Group (NASDAQ:PEGI) have all outperformed the market, and even the maligned 8point3 Energy Partners (NASDAQ:CAFD) has come close.

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B

    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017

  • [By Travis Hoium]

    Leading the charge are two yieldcos — NextEra Energy Partners (NYSE:NEP) and 8point3 Energy Partners (NASDAQ:CAFD) — and utility company AES Corporation (NYSE:AES). Here’s a look at why they’re good dividend stocks to own today.